Mouse genetic corned disease resulting from transgenic insertional mutagenesis

British Journal of Ophthalmology

Volumn 88, Issue 3, 2004, Pages 428-432

  Ramalho, J S ^b   Gregory Evans, K ^a   Huxley, C ^a   Seabra, M C ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

DYE; RAB PROTEIN; RAB27A PROTEIN, MOUSE;

ANGIOGRAPHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATARACT; CONTROLLED STUDY; CORNEA DISEASE; CORNEA ENDOTHELIUM; CORNEA EPITHELIUM; CORNEA OPACITY; CORNEA STROMA; CORNEA THICKNESS; EXPERIMENTAL MODEL; MOUSE; MUTAGENESIS; NONHUMAN; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENICS; ANIMAL; C57BL MOUSE; CONGENITAL CORNEA DYSTROPHY; EYE FUNDUS; FLUORESCENCE ANGIOGRAPHY; GENE EXPRESSION REGULATION; GENETICS; PATHOLOGY; PHENOTYPE; TRANSGENIC MOUSE;

ANIMALS; CORNEAL DYSTROPHIES, HEREDITARY; FLUORESCEIN ANGIOGRAPHY; FUNDUS OCULI; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MODELS, ANIMAL; MUTAGENESIS, INSERTIONAL; PHENOTYPE; RAB GTP-BINDING PROTEINS;

EID: 1542407118     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2003.028787     Document Type: Article

References (25)

1. Siddiqui N, Afshari NA. The changing face of the genetics of corneal dystrophies. Curr Opin Ophthalmol 2002;13:199-203.
2. Arffa RC. Diseases of the Cornea. London: Mosby, 1991.
3. Ramalho JS, Anders R, Jaissle GB, et al. Rapid degradation of dominant-negative Rab27 proteins in vivo precludes their use in transgenic mouse models. BMC Cell Biol 2002;3:26.
4. Hawes NL, Smith RS, Chang B, et al. Mouse fundus photography and angiography: a catalogue of normal and mutant phenotypes. Mol Vis 1999;5:22.
5. Okamoto N, Tobe T, Hackett SF, et al. Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization. Am J Pathol 1997;151:281-91.
6. Beermann F, Schmid E, Schutz G. Expression of the mouse tyrosinase gene during embryonic development: recapitulation of the temporal regulation in transgenic mice. Proc Natl Acad Sci U S A 1992;89:2809-13.
7. Meisler MH. Insertional mutation of 'classical' and novel genes in transgenic mice. Trends Genet 1992;8:341-4.
8. Rijkers T, Peetz A, Ruther U. Insertional mutagenesis in transgenic mice. Transgenic Res 1994;3:203-15.
9. Bloemendal H. Proctor lecture. Disorganization of membranes and abnormal intermediate filament assembly lead to cataract. Invest Ophthalmol Vis Sci 1991;32:445-55.
10. Gotz W. Transgenic models for eye malformations. Ophthalmic Genet 1995;16:85-104.
11. Grow J. Mouse models of congenital cataract. Eye 1999;13:438-44.
12. Favor J, Neuhauser-Klaus A. Saturation mutagenesis for dominant eye morphological defects in the mouse Mus musculus. Mamm Genome 2000;11:520-5.
13. Irvine AD, Corden LD, Swensson O, et al. Mutations in cornea-specific keratin K3 or K12 genes cause Meesmann's corneal dystrophy. Nat Genet 1997;16:184-7.
14. Munier FL, Korvatska E, Djemai A, et al. Kerato-epithelin mutations in four 5q31-linked corneal dystrophies. Nat Genet 1997;15:247-51.
15. Tsujikawa M, Kurahashi H, Tanaka T, et al. Identification of the gene responsible for gelatinous drop-like corneal dystrophy. Nat Genet 1999;21:420-3.
16. Akama TO, Nishida K, Nakayama J, et al. Macular corneal dystrophy type I and type II are caused by distinct mutations in a new sulphotransferase gene. Nat Genet 2000;26:237-41.
17. Glaser T, Jepeal L, Edwards JG, et al. PAX6 gene dosage effect in a family with congenital cataracts, aniridia, anophthalmia and central nervous system defects. Nat Genet 1994;7:463-71.
18. Chakravarti S, Petroll WM, Hassell JR, et al. Corneal opacity in lumican-null mice: defects in collagen fibril structure and packing in the posterior stroma. Invest Ophthalmol Vis Sci 2000;41:3365-73.
19. Stewart HS, Ridgway AE, Dixon MJ, et al. Heterogeneity in granular corneal dystrophy: identification of three causative mutations in the TGFBI (BIGH3) gene-lessons for corneal amyloidogenesis. Hum Mutat 1999;14:126-32.
20. Schmitt-Bernard CF, Guittard C, Arnaud B, et al. BIGH3 exon 14 mutations lead to intermediate type I/IIIA of lattice corneal dystrophies. Invest Ophthalmol Vis Sci 2000;41:1302-8.
21. Skonier J, Neubauer M, Madisen L, et al. cDNA cloning and sequence analysis of βig-h3, a novel gene induced in a human adenocarcinoma cell line after treatment with transforming growth factor-β. DNA Cell Biol 1992;11:511-22.
22. Ashery-Padan R, Gruss P. Pax6 lights-up the way far eye development. Curr Opin Cell Biol 2001;13:706-14.
23. Gehring WJ. The genetic control of eye development and its implications for the evolution of the various eye-types. Int J Dev Biol 2002;46:65-73.
24. Heon E, Mathers WD, Alward WL, et al. Linkage of posterior polymorphous corneal dystrophy to 20q11. Hum Mol Genet 1995;4:485-8.
25. Biswos S, Munier FL, Yardlev J, et al. Missense mutations in COL8A2, the gene encoding the alpha2 chain of type VIII collagen, cause two forms of corneal endothelial dystrophy. Hum Mol Genet 2001;10:2415-23.